You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukocyte receptor tyrosine kinase fusion-positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retro-/Prospective, Non-interventional, Cohort Study in Adult

Active, not recruiting
  • Solid Tumor, Adult
  • +2 more
    • Amiens, France
    • +3 more
    Jul 22, 2022

    Myasthenia Gravis, MuSK Trial in Cleveland, Philadelphia (Amifampridine Phosphate)

    Active, not recruiting
    • Myasthenia Gravis, MuSK
    • Amifampridine Phosphate
    • Cleveland, Ohio
    • +1 more
    Jul 21, 2022

    MuSK Myasthenia Gravis Trial (MuSK-CAART)

    Not yet recruiting
    • MuSK Myasthenia Gravis
    • MuSK-CAART
    • (no location specified)
    Jul 5, 2022

    Advanced Solid Tumor Trial in Beijing (SY-3505)

    Recruiting
    • Advanced Solid Tumor
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Sep 15, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

    Active, not recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +3 more
    • New Haven, Connecticut
    • +4 more
    Jan 27, 2023

    Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

    Recruiting
    • Breast Cancer
    • +3 more
    • Stanford, California
      Stanford University
    Feb 16, 2022

    HER2/Neu+ Uterine Serous Carcinoma Trial in Tucson, New Haven, Boston (Afatinib)

    Recruiting
    • HER2/Neu+ Uterine Serous Carcinoma
    • Tucson, Arizona
    • +2 more
    Feb 2, 2022

    EGFR Positive NSCLC Trial in Korea, Republic of (EGFR)

    Active, not recruiting
    • EGFR Positive Non-small Cell Lung Cancer
    • Anyang, Gyeonggi-do, Korea, Republic of
    • +7 more
    Jul 13, 2021

    Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)

    Terminated
    Has Results
    • Chronic Myeloid Leukemia in Chronic Phase
    • Bruxelles, Belgium
    • +9 more
    Jul 14, 2021

    Lung Tumors Trial in Gyeonggi-do, Incheon, Seoul (lazertinib(YH25448))

    Recruiting
    • Lung Neoplasms
    • Gyeonggi-do, Korea, Republic of
    • +5 more
    Apr 19, 2022

    Non Small Cell Lung Cancer Trial in China (XZP-5809-TT1 Tablet)

    Recruiting
    • Non Small Cell Lung Cancer
    • XZP-5809-TT1 Tablet
    • Beijing, Beijing, China
    • +4 more
    Mar 17, 2021

    (Korea Osimertinib Real World Evidence Study to Assess Safety

    Completed
    • Non-Small Cell Lung Cancer
      • South Korea, Korea, Republic of
        Research Site
      Sep 8, 2020

      Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer Trial in Worldwide (AZD9291 80

      Active, not recruiting
      Has Results
      • Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
      • AZD9291 80 mg/40 mg + placebo
      • +5 more
      • Anaheim, California
      • +168 more
      Nov 29, 2022

      Called EPI VITRAKVI to Compare Treatment Results in Infantile

      Completed
      • Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
      • Infantile Fibrosarcoma
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Standard of Care
      • Multiple Locations, France
        Multiple Locations
      Jan 10, 2023

      Solid Tumors Harboring NTRK Fusion Trial in Mannheim (Selitrectinib (BAY2731954))

      Completed
      • Solid Tumors Harboring NTRK Fusion
      • Selitrectinib (BAY2731954)
      • Mannheim, Baden-Württemberg, Germany
        CRS Clinical-Research-Services Mannheim GmbH
      Dec 28, 2020

      Non Small Cell Lung Cancer Trial in Worldwide (AZD9291)

      Active, not recruiting
      Has Results
      • Non Small Cell Lung Cancer
      • La Jolla, California
      • +43 more
      Nov 25, 2022

      EGFR Mutation Positive Advanced Non Small Cell Lung Cancer Trial in Worldwide (AZD3759, AZD9291)

      Completed
      • EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
      • Los Angeles, California
      • +9 more
      Jan 4, 2021

      NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)

      Active, not recruiting
      Has Results
      • Non-Small Cell Lung Cancer
      • Kogarah, Australia
      • +29 more
      Oct 20, 2022

      Breast Cancer Stage II Trial in Xi'an (Anlotinib)

      Recruiting
      • Breast Cancer Stage II
      • Xi'an, Shannxi Province, China
        Xijing Hospital Affiliated to Air Force Military Medical Univers
      Sep 25, 2022

      Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

      Terminated
      Has Results
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +12 more
      • Laboratory Biomarker Analysis
      • ROR1 CAR-specific Autologous T-Lymphocytes
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 11, 2022

      The Life After Stopping Tyrosine Kinase Inhibitors Study

      Completed
      • Leukemia, Myeloid, Chronic
      • Imatinib (Stopping their TKI)
      • +3 more
      • San Francisco, California
      • +15 more
      Jan 3, 2023

      Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

      Recruiting
      • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 1, 2022

      Resistance-associated Mutations in Metastatic Lung Cancer

      Recruiting
      • Lung Cancer
      • Liquid biopsy
      • Monza, MB, Italy
        Fondazione IRCCS San Gerardo dei Tintori
      Oct 10, 2023

      NSCLC Trial (Furmonertinib)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • (no location specified)
      Aug 10, 2023

      Non Small Cell Lung Cancer Trial in Worldwide (HM61713)

      Terminated
      • Non Small Cell Lung Cancer
      • Beverly Hills, California
      • +71 more
      Jan 17, 2021